NO960839L - Bakterieeksporterte proteiner og acellulære vaksiner som er basert på disse - Google Patents

Bakterieeksporterte proteiner og acellulære vaksiner som er basert på disse

Info

Publication number
NO960839L
NO960839L NO960839A NO960839A NO960839L NO 960839 L NO960839 L NO 960839L NO 960839 A NO960839 A NO 960839A NO 960839 A NO960839 A NO 960839A NO 960839 L NO960839 L NO 960839L
Authority
NO
Norway
Prior art keywords
pct
proteins
bacteria
nucleic acids
exported proteins
Prior art date
Application number
NO960839A
Other languages
English (en)
Other versions
NO321826B1 (no
NO960839D0 (no
Inventor
Robert H Masure
Barbara J Pearce
Elaine I Tuomanen
Original Assignee
Univ Rockefeller
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Rockefeller filed Critical Univ Rockefeller
Publication of NO960839D0 publication Critical patent/NO960839D0/no
Publication of NO960839L publication Critical patent/NO960839L/no
Publication of NO321826B1 publication Critical patent/NO321826B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0008—Oxidoreductases (1.) acting on the aldehyde or oxo group of donors (1.2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y102/00—Oxidoreductases acting on the aldehyde or oxo group of donors (1.2)
    • C12Y102/03—Oxidoreductases acting on the aldehyde or oxo group of donors (1.2) with oxygen as acceptor (1.2.3)
    • C12Y102/03003—Pyruvate oxidase (1.2.3.3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NO19960839A 1993-09-01 1996-02-29 Rekombinant DNA-molekyl, isolert polypeptid og en immunogen sammensetning inneholdende disse for beskyttelse mot Gram-positive bakterier, samt en in vitro fremgangsmate for diagnostisering av slike bakterier. NO321826B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11654193A 1993-09-01 1993-09-01
US08/245,511 US5928900A (en) 1993-09-01 1994-05-18 Bacterial exported proteins and acellular vaccines based thereon
PCT/US1994/009942 WO1995006732A2 (en) 1993-09-01 1994-09-01 Bacterial exported proteins and acellular vaccines based thereon

Publications (3)

Publication Number Publication Date
NO960839D0 NO960839D0 (no) 1996-02-29
NO960839L true NO960839L (no) 1996-04-19
NO321826B1 NO321826B1 (no) 2006-07-10

Family

ID=26814346

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19960839A NO321826B1 (no) 1993-09-01 1996-02-29 Rekombinant DNA-molekyl, isolert polypeptid og en immunogen sammensetning inneholdende disse for beskyttelse mot Gram-positive bakterier, samt en in vitro fremgangsmate for diagnostisering av slike bakterier.

Country Status (14)

Country Link
US (2) US5928900A (no)
EP (1) EP0721506B1 (no)
JP (1) JP3722834B2 (no)
AT (1) ATE332376T1 (no)
AU (1) AU709405B2 (no)
CA (1) CA2170726A1 (no)
DE (1) DE69434784T2 (no)
DK (1) DK0721506T3 (no)
ES (1) ES2267096T3 (no)
FI (1) FI960977A7 (no)
NO (1) NO321826B1 (no)
NZ (1) NZ273497A (no)
PT (1) PT721506E (no)
WO (1) WO1995006732A2 (no)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2638595A (en) * 1994-05-16 1995-12-05 Uab Research Foundation, The (streptococcus pneumoniae) capsular polysaccharide genes and flanking regions
US6245335B1 (en) 1996-05-01 2001-06-12 The Rockefeller University Choline binding proteins for anti-pneumococcal vaccines
US5834278A (en) * 1996-05-01 1998-11-10 The Rockefeller University Bacterial peptide methionine sulfoxide reductase an adhesion-associated protein, and antibiotic therapies based thereon
US6165989A (en) * 1996-05-14 2000-12-26 Smithkline Beecham Corporation Era of Streptococcus pneumoniae
EP0956289A4 (en) * 1996-08-16 2004-10-13 Smithkline Beecham Corp NOVEL PROKARYOTA POLYNUCLEOTIDES AND POLYPEPTIDES AND USES THEREOF
US5882871A (en) * 1996-09-24 1999-03-16 Smithkline Beecham Corporation Saliva binding protein
US5928895A (en) * 1996-09-24 1999-07-27 Smithkline Beecham Corporation IgA Fc binding protein
US5882896A (en) * 1996-09-24 1999-03-16 Smithkline Beecham Corporation M protein
ATE348887T1 (de) * 1996-10-31 2007-01-15 Human Genome Sciences Inc Streptococcus pneumoniae antigene und impfstoffe
AU5355398A (en) 1996-11-12 1998-06-03 Regents Of The University Of Minnesota C3 binding protein of (streptococcus pneumoniae)
US20040242522A1 (en) * 1997-02-14 2004-12-02 Volkin David B. Polynucleotide vaccine formulations
US6676943B1 (en) 1997-04-24 2004-01-13 Regents Of The University Of Minnesota Human complement C3-degrading protein from Streptococcus pneumoniae
WO2000005378A2 (en) * 1998-07-22 2000-02-03 Id-Lelystad Instituut Voor Dierhouderij En Diergezondheid B.V. Streptococcus suis vaccines and diagnostic tests
EP1783224A3 (en) * 1998-07-27 2007-08-15 Sanofi Pasteur Limited Streptococcus pneumoniae proteins and nucleic acid molecules
US20030134407A1 (en) 1998-07-27 2003-07-17 Le Page Richard William Falla Nucleic acids and proteins from Streptococcus pneumoniae
EP1144640A3 (en) * 1998-07-27 2001-11-28 Microbial Technics Limited Nucleic acids and proteins from streptococcus pneumoniae
US6936252B2 (en) 1998-07-27 2005-08-30 Microbial Technics Limited Streptococcus pneumoniae proteins and nucleic acid molecules
EP1801218A3 (en) * 1998-07-27 2007-10-10 Sanofi Pasteur Limited Nucleic acids and proteins from streptococcus pneumoniae
WO2000006737A2 (en) * 1998-07-27 2000-02-10 Microbial Technics Limited Streptococcus pneumoniae proteins and nucleic acid molecules
EP1624064A3 (en) * 1998-07-27 2006-05-10 Microbial Technics Limited Nucleic acids and proteins from streptococcus pneumoniae
US7098182B2 (en) 1998-07-27 2006-08-29 Microbial Technics Limited Nucleic acids and proteins from group B streptococcus
WO2000006736A2 (en) * 1998-07-27 2000-02-10 Microbial Technics Limited Nucleic acids and proteins from group b streptococcus
CA2355364C (en) 1998-12-21 2014-03-18 Medimmune, Inc. Streptococcus pneumoniae proteins and immunogenic fragments for vaccines
GB9921125D0 (en) * 1999-09-07 1999-11-10 Microbial Technics Limited Proteins
AU5345901A (en) * 2000-04-13 2001-10-30 Univ Rockefeller Enhancement of antibody-mediated immune responses
EP1205552A1 (en) 2000-11-09 2002-05-15 ID-Lelystad, Instituut voor Dierhouderij en Diergezondheid B.V. Virulence of streptococci, involving ORFs from Streptococcus suis
WO2002061070A2 (en) 2001-02-02 2002-08-08 Id-Lelystad, Instituut Voor Dierhouderij En Diergezondheid B.V. Environmentally regulated genes, involved in the virulence of streptococcus suis
AU2002319764A1 (en) * 2001-08-03 2003-02-17 Elitra Pharmaceuticals, Inc. Nucleic acids of aspergillus fumigatus encoding industrial enzymes and methods of use
NO20026286D0 (no) * 2002-12-30 2002-12-30 Amersham Health As Nye peptider
RU2286576C2 (ru) * 2004-12-21 2006-10-27 Волгоградский научно-исследовательский противочумный институт Способ выявления перекрестнореагирующих антигенов возбудителей мелиоидоза, сапа, чумы, туляремии и туберкулеза
EP2023143A1 (en) * 2007-08-06 2009-02-11 Boehringer Ingelheim Vetmedica Gmbh Immunogenic streptococcus proteins
EP2897638A1 (en) 2012-09-24 2015-07-29 Montana State University-Bozeman Recombinant lactococcus lactis expressing escherichia coli colonization factor antigen i (cfa/i) fimbriae and their methods of use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0274425B1 (en) * 1987-01-06 1993-12-15 Asahi Kasei Kogyo Kabushiki Kaisha Pyruvate oxidase, its preparation and use
JP3237842B2 (ja) * 1988-12-16 2001-12-10 オランダ国 ニューモリシンミュータント及びそれから製造されたニューモコッカルワクチン
FI933580L (fi) * 1991-02-15 1993-10-13 Uab Research Foundation Strukturgen av pneumokockprotein
WO1993010238A1 (en) * 1991-11-14 1993-05-27 The Government Of The United States Of America As Represented By The Department Of Health And Human Services Pneumococcal fimbrial protein a vaccines
JPH07502896A (ja) * 1992-01-08 1995-03-30 ザ ロックフェラー ユニバーシティ 連鎖球菌の多官能性表面タンパク

Also Published As

Publication number Publication date
ATE332376T1 (de) 2006-07-15
FI960977L (fi) 1996-04-30
NO321826B1 (no) 2006-07-10
WO1995006732A3 (en) 1995-06-01
JP3722834B2 (ja) 2005-11-30
US5981229A (en) 1999-11-09
DK0721506T3 (da) 2006-10-30
AU7680994A (en) 1995-03-22
ES2267096T3 (es) 2007-03-01
US5928900A (en) 1999-07-27
FI960977A0 (fi) 1996-03-01
EP0721506B1 (en) 2006-07-05
NO960839D0 (no) 1996-02-29
PT721506E (pt) 2006-10-31
JPH09504686A (ja) 1997-05-13
DE69434784T2 (de) 2007-06-14
EP0721506A1 (en) 1996-07-17
DE69434784D1 (de) 2006-08-17
NZ273497A (en) 1998-03-25
CA2170726A1 (en) 1995-03-09
FI960977A7 (fi) 1996-04-30
WO1995006732A2 (en) 1995-03-09
AU709405B2 (en) 1999-08-26

Similar Documents

Publication Publication Date Title
NO960839D0 (no) Bakterieeksporterte proteiner og acellulære vaksiner som er basert derpå
KR100202128B1 (en) Vaccine against lyme disease
EA200100565A1 (ru) Новые стрептококковые антигены
DK0634490T3 (da) Xylanase afledt fra en bacillusart, udtrykkelsesvektorer for sådan en xylanase og andre proteiner, værtsorganismer derfor og anvendelse deraf
EP1900818A3 (en) Neisserial antigens
MXPA02001911A (es) Anticuerpos ctla-4 humanos y sus usos.
PT698105E (pt) Sequencias de nucleotidos para o controlo da expressao de sequencias de adn num hospedeiro celular
DK0418945T3 (da) Forgreningsenzym og dets anvendelse
DK0519218T3 (da) Hybridplasmid for 38 kDa-antigenet fra M. tuberculosis, E. coli som vært, 38 kDa-antigenet og et ca. 33 kDa-protein
NO20005152D0 (no) Human protease og anvendelse av slik protease for farmasøytiske anvendelser og for reduksjon av allergenisiteten til ikke-humane proteiner
DK0840792T3 (da) (S)-hydroxynitrillyase fra Hevea brasiliensis
DE69116803D1 (de) Peroxidase-Gen von mikrobischem Ursprung
PT648836E (pt) Transactivador do mhc de classe ii (ciita) e suas utilizacoes
DE59410428D1 (de) Cholesterinoxidase aus brevibacterium sterolicum
GR3036369T3 (en) Vaccines based on streptokinase.
GR3030288T3 (en) Substituted heteroarylalkylthiopyridines for controlling helicobacter bacteria.
AU6999287A (en) Insecticidal proteinaceous substance
NO20011961D0 (no) PRV-1-genet og anvendelsen av dette
DE60114876D1 (de) DEKONTAMINATION VON PRIONHALTIGEM (z.B. BSE-AGENS ENTHALTENDEM) TIERFUTTER

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees